Horizon Discovery Inks Additional Licensing Pacts with U of Washington
December 14, 2009
Horizon Discovery Inks Additional Licensing Pacts with U of Washington
Horizon will use UW gene-engineering tech to develop mammalian cell lines for bioproduction and pluripotent human stem cells for predicting cancer drug responses.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Horizon Discovery Launches Companion Dx Subsidiary
January 5, 2010 / GenomeWeb Daily News - Horizon Diagnostics, Diatech Reach Distribution Deal for Molecular Reference Standards
April 15, 2013 / GenomeWeb Daily News - ACMG Presenters Discuss Whole-Exome Sequencing in Refining Clinical Diagnoses
March 22, 2013 / GenomeWeb Daily News - NHGRI-Funded Mendelian Centers Enter Second Year of Effort to Increase Number of Known Disorders
February 13, 2013 / Clinical Sequencing News - New Products: University of Washington's UW-Onco-Plex; Sequenta's ClonoSight; LifeCodexx's PrenaTest
February 13, 2013 / Clinical Sequencing News